Using our panel of validated splicing events, we then asked whether some of the splicing changes induced by EBV infection were also induced by the activation of primary B cells with a combination of CD40 ligand (CD40L) and Interleukin 4 (IL4) (37). This evidence concerns the gene IL4 and Epstein-Barr virus infection.